Natalia Kunst

Image of Natalia Kunst
Norwegian version of this page
Username
Visiting address Forskningsveien 3A Harald Schjelderups hus 0373 Oslo
Postal address Postboks 1089 Blindern 0317 Oslo

Academic interests

Decision-analytic modeling, cost-effectiveness analyses, value of information (VOI), health economic evaluation, disease mathematical modeling, Bayesian methods and decision theory, causal inference

Courses Tought

  • Fall 2019 -  Teaching Fellow for the graduate-level course Cost-Effectiveness Analysis and Decision Making [HPM 570], Yale University School of Public Health, Course Faculty: A. David Paltiel
  • Spring 2019 - Teaching Fellow for Advanced Topics in Decision-making in Medicine [EWP02], Erasmus Medical Center, Course Faculty: Myriam Hunink

Background

  • 2019 – Postgraduate Research Fellow, Yale University School of Medicine

  • 2018 –   Visiting PhD Candidate, Public Health Modeling Unit Yale University School of Public Health

  • 2017 –   PhD Candidate in Health Decision Sciences, University of Oslo

  • 2017 –   PhD Research Fellow, Decision Modeling Center VUmc Amsterdam

  • 2015 –   Senior Health Economist, LINK Medical Research

  • PhD courses and research activities, Department of Economics, Gdansk University of Technology, 2011-2013  

  • MSc, Department of Economics, Gdansk University of Technology, 2011

  • MSc, Department of Economics and Economic Policy, Gdynia University, 2011

Awards

  • Gold medal for outstanding academic results and scientific research during the master’s program from the Rector of Gdansk University of Technology.
  • Award for the best master’s thesis in Labor Economics organized by the Regional Labor Office in Gdansk.

Collaboration

 

Tags: Health economics, Economic evaluation

Publications

  • Tuffaha, Haitham; Rothery, Claire; Kunst, Natalia; Jackson, Chris; Strong, Mark & Birch, Stephen (2021). A Review of Web-Based Tools for Value-of-Information Analysis. Applied Health Economics and Health Policy. ISSN 1175-5652. 19(5), p. 645–651. doi: 10.1007/s40258-021-00662-4.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Lindau, Stacy T. [Show all 8 contributors for this article] (2021). Understanding Regional Variation in the Cost of Breast Cancer Screening among Privately Insured Women in the United States. Medical Care. ISSN 0025-7079. 59(5), p. 437–443. doi: 10.1097/MLR.0000000000001506.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Show all 7 contributors for this article] (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2(HER2)–Positive Breast Cancer. JAMA Network Open. ISSN 2574-3805. doi: 10.1001/jamanetworkopen.2020.27074.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle; Schrag, Deborah & Kuntz, Karen (2020). Estimating population-based recurrence rates of colorectal cancer over time in the United States. Cancer Epidemiology, Biomarkers and Prevention. ISSN 1055-9965. 29(12), p. 2710–2718. doi: 10.1158/1055-9965.EPI-20-0490.
  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018. PharmacoEconomics (Auckland). ISSN 1170-7690. doi: 10.1007/s40273-020-00942-2.
  • Kunst, Natalia; Wilson, Edward C.F.; Glynn, David; Alarid-Escudero, Fernando; Baio, Gianluca & Brennan, Alan [Show all 14 contributors for this article] (2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value in Health. ISSN 1098-3015. 23(6), p. 734–742. doi: 10.1016/j.jval.2020.02.010.
  • Heath, Anna; Kunst, Natalia; Jackson, Christopher; Strong, Mark; Alarid-Escudero, Fernando & Goldhaber-Fiebert, Jeremy D. [Show all 9 contributors for this article] (2020). Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Medical decision making. ISSN 0272-989X. doi: 10.1177/0272989X20912402.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Show all 7 contributors for this article] (2020). Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.0262.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando; Paltiel, A. David & Wang, Shi-Yi (2019). A value of information analysis of research on the 21-gene assay for breast cancer management. Value in Health. ISSN 1098-3015. 22(10), p. 1102–1110. doi: 10.1016/j.jval.2019.05.004.
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2019). Cost-effectiveness of diagnostic algorithms for peanut allergy in children. Journal of Allergy and Clinical Immunology. ISSN 0091-6749. 143(3), p. 1243–1246. doi: 10.1016/j.jaci.2018.10.050.

View all works in Cristin

  • Kim, David D.; Silver, Madison C.; Kunst, Natalia; Cohen, Joshua T.; Ollendorf, Daniel A. & Neumann, Peter J. (2020). Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974–2018 (PharmacoEconomics, (2020), 38, 10, (1135-1145), 10.1007/s40273-020-00942-2). PharmacoEconomics (Auckland). ISSN 1170-7690. 38(12). doi: 10.1007/s40273-020-00968-6.
  • Byrne, Jennifer & Kunst, Natalia (2020). Mammography for women aged 40 to 49 years associated with high, widely variable costs. [Internet]. Healio.
  • Kunst, Natalia & Mamoun, Fred (2020). Breast Cancer Screening Costs High, Benefits Uncertain, for Women in 40s. [Internet]. Yale News.
  • Dunleavy, Brian P. & Kunst, Natalia (2020). Less than half of women in their 40s screened for breast cancer each year. [Internet]. United Press International.
  • Kunst, Natalia (2020). Quantifying the value of further research to improve 21-gene assay decision-making in breast cancer.
  • Kunst, Natalia (2020). Value of Information analysis in medical decision making.
  • Kunst, Natalia & Gross, Cary (2020). Breast Cancer Screening and Health Care Costs—Reply. JAMA Internal Medicine. ISSN 2168-6106. doi: 10.1001/jamainternmed.2020.2355.
  • Furlow, Bryant & Kunst, Natalia (2019). All Women with Breast Cancer Should Undergo Multigene Testing, Study Suggests. [Journal]. Cancer Network.
  • Kunst, Natalia; Wang, Shi-Yi; Hood, Annette; Mougalian, Sarah; DiGiovanna, Michael & Adelson, Kerin [Show all 7 contributors for this article] (2019). Cost-effectiveness of different neoadjuvant followed by adjuvant treatment strategies for women with HER2-positive breast cancer (Spotlight Session).
  • Kunst, Natalia (2019). Finding the optimal diagnostic algorithm for children with peanut allergy: A cost-effectiveness study.
  • Kunst, Natalia (2019). Diagnosing peanut allergy in children: A cost-effectiveness analysis of diagnostic algorithms.
  • Kunst, Natalia; Grosse, Scott; Chen, Yao-Hsuan; Kim, David & Wisløff, Torbjørn (2019). Overview of various recommendations for health economic perspective. Symposium: Value for whom? Choice and Consequences of Perspective in Economic Evaluations.
  • Kunst, Natalia; Long, Jessica; Xu, Xiao; Busch, Susan; Kyanko, Kelly & Richman, Ilana [Show all 7 contributors for this article] (2019). Utilization and costs of breast cancer screening for women in their 40s in a privately insured US population.
  • Kunst, Natalia; Wilson, Ed; Alarid-Escudero, Fernando; Baio, Gianluca; Brennan, Alan & Fairley, Michael [Show all 14 contributors for this article] (2019). Practical Considerations for the Efficient Computation of the Expected Value of Sample Information to Prioritize Research in Health Care.
  • Kunst, Natalia; Alarid-Escudero, Fernando; Aas, Eline; Coupe, Veerle & Kuntz, Karen (2019). Real-World Recurrence Rates of Colorectal Cancer over Time.
  • Kunst, Natalia R. (2019). A comprehensive value of information analysis to assess the state of the evidence and quantify uncertainty on the use of 21-gene assay Oncotype DX.
  • Kunst, Natalia R. (2018). Future research on the 21-gene assay for breast cancer: A value of information analysis.
  • Kunst, Natalia R. (2018). What is the value of further research on the 21-gene assay for breast cancer management?
  • Kunst, Natalia R.; Lindvik, Helene; Carlsen, Kai-Håkon; Håland, Geir; Jørgensen, Eivind & Carlsen, Karin C. Lødrup (2018). Diagnosing Peanut Allergy in Children: A Cost-Effectiveness Analysis of Diagnostic Algorithms.
  • Kunst, Natalia R.; Alarid-Escudero, Fernando & Wang, Shi-Yi (2018). Decisions on Further Research for 21-Gene Assay in Real-World Management of Breast Cancer: A Value of Information Analysis. [Lee B. Lusted Award Finalist].
  • Kunst, Natalia R. (2017). Health economic modeling to determine the optimal diagnostic algorithm for nut allergy.

View all works in Cristin

Published Jan. 4, 2018 2:03 PM - Last modified Aug. 25, 2021 9:47 AM